Convergent Science Virtual Cancer Center

The CSVCC is a convergent approach to cancer research that combines advances from diverse scientific disciplines to improve outcomes for patients.

[Dana-Farber News @DanaFarberNews]

New research from @DanaFarber’s @SarahJHill6 reveals that as CDK4/6 inhibitors are being investigated as a possible treatment in endometrial cancer, RB function-predictive transcriptional signatures may be a relevant biomarker to help predict response to therapy.

➡️https://t.co/8Iu1STIRtZ

[Convergent Science Virtual Cancer Center @_CSVCC]

Congratulations, @HindRafei!!

[Hind Rafei @HindRafei]

Still pinching myself! So excited to receive a 2026 @CancerResearch (CRI) CLIP Investigator Award! I am deeply thankful to CRI, led by @ay_zhou, for its vision and commitment to investing in bold science and big ideas. It's so humbling to see all my idols on CRI’s Scientific Advisory Council recognize the value in our work. No pressure at all! 😅

Science is meant to be open, shared, and collaborative. This project started after a casual conversation I had with my brilliant lab neighbor (and now partner!) @xufeng_chen. So grateful to him, to @UTMDAnderson for providing the supportive environment in which ambitious ideas can grow, and to the amazing members of the #RafeiLab, whose creativity, persistence, and hard work make everything we do possible.

A huge congratulations to all the other 2026 CLIP awardees @BhardwajLab @CSHinrichsMD Margaret Callahan @SLentzsch @joshrveatch Deric Wheeler! So humbling to join this extraordinary community of investigators united by the shared goal of curing cancer through innovative immunotherapies. Thanks again to CRI for believing in our science and giving us the opportunity to pursue it. Now, let’s get to work! 🧪🔬

https://t.co/JgvK8GTCrB

[Convergent Science Virtual Cancer Center @_CSVCC]

@HindRafei @DeptofWar Congratulations! Welcome to CSVCC!

[Convergent Science Virtual Cancer Center @_CSVCC]

Congratulations to Lindsay Schwartz, Cohort 3 Scholar, on receiving a 2026 @ConquerCancerFd Career Development Award! An outstanding achievement—great work! 🎉

[Conquer Cancer, the ASCO Foundation @ConquerCancerFd]

We're thrilled to officially announce the 2026 class of Conquer Cancer Grants and Awards recipients! 🔬 These grants empower the next generation of physician-scientists to turn innovative ideas into clinical breakthroughs. Congratulations to the new class—see you in Chicago for #ASCO26!

Full list of recipients here: https://t.co/Ltov9bTGYi

#ResearchConquersCancer #ConquerCancer @ASCO

[University of Arizona Research @uazresearch]

Dr. Dan Theodorescu, director of the @UAZCancer, has been awarded the prestigious Spence Medal by the American Association of Genitourinary Surgeons, honoring his lifetime of discoveries in cancer research and precision medicine. Congratulations! More: https://t.co/S31iO3HP9q

[Convergent Science Virtual Cancer Center @_CSVCC]

@jonathanMtsai Congratulations, Jonathan!

[Convergent Science Virtual Cancer Center @_CSVCC]

Congratulations to Cohort 3 Scholar, Jonathan Tsai, for being a recipient of AACR Trailblazer Cancer Research Grant!

[AACR @AACR]

Congratulations to the AACR Trailblazer Cancer Research Grants recipients, supported by @pfizer. AACR’s largest-ever grant program has awarded 15 early-stage and mid-career investigators $1million each to establish novel, highly creative research projects. https://t.co/dXsYggjXmw

[Convergent Science Virtual Cancer Center @_CSVCC]

Wrapping up a fantastic weekend at the CSVCC Workshop at @USCWrigley! Great science, inspiring conversations, new connections, and an amazing group of people! #scholars #cancerresearch #convergentscience #militaryhealth

[Justin Lathia, PhD 🧠🕺🏽 @JustinLathia]

Excited to be at the @_CSVCC retreat, inspiring start honoring Adam Hayden - his memory will live on and inspire us to continue to innovate in #CancerResearch

[Convergent Science Virtual Cancer Center @_CSVCC]

@JustinLathia @PeiwenChen9 Thank you for joining us and supporting CSVCC and @PeiwenChen9!

[Convergent Science Virtual Cancer Center @_CSVCC]

Thrilled to feature Scholar, Dr. Nilay Sethi, on his new work shows how reprogramming tumors, forcing them to “grow up,” could transform colorectal cancer treatment. #ColorectalCancer #CancerResearch
🔗 https://t.co/GmKnSORnVq

[Convergent Science Virtual Cancer Center @_CSVCC]

Thrilled to highlight Dr. Kun-Hsing Yu whose team helped develop the groundbreaking “CHIEF” AI model — trained on 15 million pathology images across 19 cancer types. #Cancerdetection #AIinMedicine #Pathology
Read more here:
https://t.co/9JPvoVHpDY

[University of Arizona Research @uazresearch]

A @UAZCancer researcher received a $1.7M grant to continue the Convergent Science Virtual Cancer Center, with the University of Southern California, training researchers to address cancer risks in military communities. More: https://t.co/InKtX3CPLI

[Convergent Science Virtual Cancer Center @_CSVCC]

We are excited to welcome seven new Scholars to the CSVCC! Each of them brings valuable expertise and perspectives that will strengthen our convergent science community. To learn more about our Scholars and the work of the CSVCC, visit https://t.co/HBspa0RfXB.

[Peiwen Chen @PeiwenChen9]

Our work on Macrophages and Breast cancer brain metastasis is finally out @PNASNews https://t.co/CI4rUFoza1 Thanks editors，reviewers, and all authors.

[Grant Rowe @bloodandtime1]

I am looking forward to presenting a short talk on our work on macrophage ontogeny at the @ISEHSociety annual meeting.

[Sethi_Lab @LabSethi]

A great collaboration with my friend @JunQiLab. We screened a small molecule library targeting epigenetic regulators curated by Jun’s team using our dual reporter system. The ensuing mechanistic work required innovative chemical and rigorous molecular biology.

[JCI insight @JCI_insight]

Disrupting cell communication in glioblastoma—

@PeiwenChen9 and team @ClevelandClinic discover GPNMB mediates bidirectional communication between GBM stem cells and tumor-associated macrophages and microglia: https://t.co/H1n5h9yqy4

[Journal of Clinical Investigation @jclinicalinvest]

Improving immunotherapy in glioblastoma!

@PeiwenChen9 & team @ClevelandClinic discover targeting legumain—which promotes infiltration of tumor-associated macrophages via the GSK3β/STAT3 pathway—has anti-tumor effects and improves immunotherapy in preclinical GBM models: https://t.co/GDP0isNvKp

[Peiwen Chen @PeiwenChen9]

Happy to share our work out at @jclinicalinvest We identified a new tumor-macrophage interaction contributing to GBM progression/immunosuppression and found that targeting the symbiosis sensitizes GBM to immunotherapy. Huge thanks to editors and reviewers. https://t.co/ziCHyA6WN1